The Editor's Roundtable: Lipid Management Beyond Statins—Reducing Residual Cardiovascular Risk

  • Vincent E. Friedewald Jr.
    Corresponding author: Tel: 512-264-1611; fax 512-264-7034
    Assistant Editor, The American Journal of Cardiology, Clinical Professor, Department of Internal Medicine, The University of Texas Medical School at Houston, Houston, Texas, and Adjunct Research Professor, College of Science, University of Notre Dame, Notre Dame, Indiana
    Search for articles by this author
  • Christie M. Ballantyne
    Director, Center for Cardiovascular Prevention, The Methodist DeBakey Heart Center and Baylor College of Medicine, and Professor, Section of Atherosclerosis, Department of Medicine, Baylor College of Medicine, Houston, Texas
    Search for articles by this author
  • Michael H. Davidson
    Clinical Professor, Director of Preventive Cardiology, The University of Chicago, Pritzker School of Medicine, and Executive Medical Director, Radiant Research, Chicago, Illinois
    Search for articles by this author
  • John R. Guyton
    Associate Professor of Medicine, Division of Endocrinology, Metabolism, and Nutrition, and Assistant Professor of Pathology, Duke University Medical Center, Durham, North Carolina
    Search for articles by this author
  • William C. Roberts
    Editor-in-Chief, The American Journal of Cardiology and Baylor University Medical Center Proceedings, Executive Director, Baylor Heart and Vascular Institute, Baylor University Medical Center, and Dean, A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System, Dallas, Texas
    Search for articles by this author
      This CME activity is supported by an educational grant from Abbott Laboratories, Abbott Park, Illinois.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.
        JAMA. 2001; 285: 2486-2497
        • Smith S.C.
        • Allen J.
        • Blair S.N.
        • Bonow R.O.
        • Brass L.M.
        • Fonarow G.C.
        • Grundy S.M.
        • Hiratzka L.
        • Jones D.
        • Krumholz H.M.
        • et al.
        AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.
        J Am Coll Cardiol. 2006; 47: 2130-2139
        • Davidson M.H.
        • Robinson J.G.
        Safety of aggressive lipid management.
        J Am Coll Cardiol. 2007; 49: 1753-1762
        • Kastelein J.J.
        • Sager P.T.
        • de Groot E.
        • Veltri E.
        Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia.
        Am Heart J. 2005; 149: 234-239
        • Canner P.L.
        • Berge K.G.
        • Wenger N.K.
        • Stamler J.
        • Friedman L.
        • Prineas R.J.
        • Friedewald W.
        Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin.
        J Am Coll Cardiol. 1986; 8: 1245-1255